MDxHealth SA Stock-Based Compensation Growth & History (MDXH)

MDxHealth SA's stock-based compensation was $2.2M for fiscal 2025.

View full MDxHealth SA company overview

MDxHealth SA annual stock-based compensation history

MDxHealth SA annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-12-31$2.2M$486,000+28.17%
20242024-12-31$1.7M$1.1M+159.40%
20232023-12-31$665,000−$202,000−23.30%
20222022-12-31$867,000−$355,000−29.05%
20212021-12-31$1.2M−$73,000−5.64%
20202020-12-31$1.3M$423,000+48.51%
20192019-12-31$872,000

MDxHealth SA stock-based compensation trends

Over the last five fiscal years, MDxHealth SA's stock-based compensation increased from $1.3M to $2.2M, a change of $916,000. The latest reported quarter, Q2 2026, shows $605,000.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review MDxHealth SA source filings ↗

Community posts

It’s quiet here.

No posts about MDXH yet. Start the conversation.

Write the first post